What is the management approach for Subdural Hematoma (SDH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Approach for Subdural Hematoma (SDH)

The management of subdural hematoma requires prompt surgical evacuation for acute SDH with thickness >10mm or midline shift >5mm, regardless of Glasgow Coma Scale score, while small asymptomatic hematomas can be managed conservatively with close monitoring. 1

Initial Assessment and Classification

  • SDH is classified as acute, subacute, or chronic based on time since injury and imaging characteristics 2
  • Initial management follows Emergency Neurological Life Support guidelines, focusing on maintaining ICP <22 mmHg, CPP >60 mmHg, MAP 80-110 mmHg, and PaO2 >60 mmHg 2
  • Immediate laboratory workup must include coagulation studies (PT, PTT, INR, platelet count) to identify and correct any coagulopathy 3
  • CT scan is the primary imaging modality to determine location, size, midline shift, and presence of other intracranial injuries 3

Surgical Management Criteria

  • Surgical evacuation is recommended for:
    • SDH thickness >10mm or midline shift >5mm, regardless of GCS score 1
    • Comatose patients (GCS <9) with SDH <10mm and midline shift <5mm if:
      • GCS decreased by ≥2 points between injury and admission
      • Patient presents with asymmetric or fixed/dilated pupils
      • ICP exceeds 20 mmHg 1
  • Surgical evacuation should be performed as soon as possible when indicated 1
  • Craniotomy with or without bone flap removal is preferred over burr holes for acute SDH 3

Medical Management

  • All comatose patients (GCS <9) with acute SDH should undergo ICP monitoring 1
  • Cerebral perfusion pressure should be maintained between 60-70 mmHg in the absence of multi-modal monitoring 4
  • For intracranial hypertension, mannitol 20% or hypertonic saline solution at a dose of 250 mOsm can be administered over 15-20 minutes 4
  • Seizure prophylaxis should be administered, especially in the acute setting 2
  • Anticoagulation or antiplatelet medications should be reversed if neurosurgical intervention is anticipated or until hemorrhage stabilizes on imaging 2

Chronic Subdural Hematoma Management

  • Burr-hole drainage with subgaleal drains remains the gold standard for symptomatic chronic SDH 5
  • Small or asymptomatic subdural hematomas can be managed conservatively 4
  • Middle meningeal artery embolization is an emerging treatment option that may reduce recurrence rates in chronic SDH 5

Post-operative Care

  • Patients require ICU-level care with monitoring for:
    • Resolution of pneumocephalus
    • Signs of SDH reaccumulation
    • Management of increased intracranial pressure
    • Seizure control 3
  • Patients should be positioned with head elevated as comfortable 4
  • Thromboprophylaxis should be considered during immobilization following procedures 4

Follow-up and Monitoring

  • Clinical assessment and imaging follow-up are essential to detect reaccumulation or complications 3
  • Recurrence remains a principal complication (9-33%), occurring more commonly with older age and bilateral SDHs 5
  • Patients should be advised to seek urgent medical attention for new-onset severe headache, neurological deficits, or altered mental status 4

Outcome Considerations

  • Recent data suggests that trauma centers with higher rates of surgical intervention for traumatic SDH have lower inpatient mortality and higher odds of favorable discharge 6
  • This effect is most pronounced among patients with abnormal pupillary examination findings 6
  • The prognosis depends on multiple factors including age, initial GCS, pupillary reactivity, and time to treatment 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.